Global Glycomics Glycobiology Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2025 –2032 |
Market Size (Base Year) |
USD 24.43 Billion |
Market Size (Forecast Year) |
USD 70.66 Billion |
CAGR |
|
Major Markets Players |
全球糖组学/糖生物学市场,按产品(酶、试剂盒、试剂和化学品、仪器、碳水化合物)、应用(药物发现和开发、疾病诊断、其他应用)、最终用户(学术研究机构、制药和生物技术公司、临床实验室)划分——行业趋势和预测到 2029 年。
糖组学/糖生物学市场分析和规模
细胞存活最常见的改变之一是聚糖的附着。存在两种类型的糖基化。一种是 N 连接糖基化:天冬酰胺聚糖附着;另一种是 O 连接糖基化:当聚糖与丝氨酸或苏氨酸连接时。糖组学是一门快速发展的科学学科,专注于解释聚糖如何在生物系统中发挥作用。
Data Bridge Market Research 分析,糖组学/糖生物学市场规模在 2021 年为 164 亿美元,到 2029 年将飙升至 474.4 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 14.2%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
糖组学/糖生物学市场范围和细分
报告指标 |
细节 |
预测期 |
2022 至 2029 年 |
基准年 |
2021 |
历史岁月 |
2020(可定制为 2014 - 2019) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
产品(酶、试剂盒、试剂和化学品、仪器、碳水化合物)、应用(药物研发、疾病诊断、其他应用)、最终用户(学术研究机构、制药和生物技术公司、临床实验室) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
默克公司(德国)、安捷伦科技公司(美国)、赛默飞世尔科技公司(美国)、岛津制作所(日本)、Takara Bio Inc.(日本)、Waters Corporation(美国)、Asparia Glycomics SL(西班牙)、Bio-Techne(美国)、Bruker(美国)、丹纳赫(美国)、RayBiotech、Life Inc.(美国)、Z Biotech LLC(美国)、Chemily Glycoscience(美国)、Dextra Laboratories Ltd.(英国)、Lectenz Bio(美国)和 Ludger Ltd.(英国) |
市场机会 |
|
Market Definition
The study of saccharides, which are extensively distributed in nature and are also thought as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Each and every living thing contains glycans. Biotechnology, biomedicine, and basic research are all interested in glycobiology's rapidly developing biological topic.
Glycomics/Glycobiology Market Dynamics
Drivers
- Technological advancements
Technological advancements are thought to promote corporate expansion. Other important aspects that operate as determinants include rising analysis spending by various administration groups and the development of novel drugs by biotechnology and pharmaceutical firms. Additionally, throughout the 2022–2029 forecast period, increasing interest in proteomics examination learnings is anticipated to fuel market growth.
- Rising R&D expenditures
The market is expanding primarily due to rising glycomics research efforts, rising R&D expenditures by pharmaceutical and biotechnology firms, and expanding proteomics sales. On the other hand, developing nations like China and India provide profitable chances for business in this sector.
- Rise in the geriatric population
The rising prevalence of disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the global glycomics/glycobiology market.
Opportunities
The market for glycomics and glycobiology is being driven primarily by rising investments in research and development by pharmaceutical and biotechnology businesses and expansion in the proteomics sector. For other businesses in this industry, developing nations provide lucrative opportunities.
Restraints/Challenges
On the other hand, the huge expense of devices will obstruct the market's growth rate.
This glycomics/glycobiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycomics/glycobiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Glycomics/Glycobiology Market
In order to combat the COVID-19 epidemic, governments from all over the world work with pharmaceutical and biotech businesses. This collaboration ranges from helping to develop vaccines to preparing for issues with the pharmaceutical supply chain. Currently, there are 115 vaccine candidates and about 155 chemicals in the R&D pipeline. In addition, there has been a substantial rise in demand for commonly prescribed drugs like hydroxychloroquine, which is used to treat COVID-19. Due to the dearth of these treatments in many industrialised countries, there is a huge market opportunity for manufacturers of COVID-19 management therapies. The demand for COVID-19 vaccines and treatment drugs is expected to result in significant growth for the pharmaceutical and biotechnology industries in the upcoming years.
Global Glycomics/Glycobiology Market Scope
The glycomics/glycobiology market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Enzymes
- Glycosidases and Neuramidases
- Glycosyltransferases and Sialytransferases
- Other Enzymes
- Carbohydrate kinases
- Carbohydrate sulfotransferases
- Protein sulfotransferases
- Sulfatases
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments
- electrophoresis instruments
- NMR instruments
- HPLC columns
- Kits
- Glycan Releasing Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Other Kits
- Glycan detection kits
- Glycan enrichment kits
- Glycan sample preparation kits
- Carbohydrates
- Oligosaccharides
- Monosaccharides
- Other Carbohydrates
- Rare sugars
- Glycoproteins
- Glycolipids
- Glycol peptides
- Reagents and Chemicals
Application
- Drug Discovery and Development
- Disease Diagnostics
- Other Applications
- Virology
- Cell biology
- Microbiology
End-user
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
Glycomics/Glycobiology Market Regional Analysis/Insights
The glycomics/glycobiology market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the glycomics/glycobiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
由于糖组学研究资金的增加、制药公司用于开发新药的研发支出的增加以及必要人员的距离较近,北美在糖组学/糖生物学市场中占据主导地位。
由于人们健康意识的增强和对先进医疗技术的需求不断增加,预计亚太地区将在 2022 年至 2029 年的预测期内以最高增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和糖组学/糖生物学市场份额分析
糖组学/糖生物学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对糖组学/糖生物学市场的关注有关。
糖组学/糖生物学市场的一些主要参与者包括:
- 默克集团(德国)
- 安捷伦科技公司(美国)
- 赛默飞世尔科技公司(美国)
- 岛津制作所(日本)
- Takara Bio Inc.(日本)
- 沃特世公司(美国)
- Asparia Glycomics SL(西班牙)
- Bio-Techne (美国)
- 布鲁克 (美国)
- 丹纳赫(美国)
- RayBiotech, Life Inc.(美国)
- Z Biotech LLC(美国)
- Chemily Glycoscience(美国)
- Dextra Laboratories Ltd.(英国)
- Lectenz Bio(美国)
- Ludger Ltd.(英国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.